CHAF1A and glioblastoma: It has been shown that CRISPR-Cas9 mediated knockout of Chromatin assembly factor 1 subunit A (CHAF1A) gene, which is associated with poor prognosis of GBM, can trigger apoptosis in two GBM cell lines U251 and U87MG [65].